- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Progressive Care Issues Update on Recent Legal Proceedings
Progressive Care (OTC PINK:RXMD) has issued an update on its lawsuit against MIDAM Ventures, LLC.
Progressive Care (OTC PINK:RXMD) has issued an update on its lawsuit against MIDAM Ventures, LLC.
As quoted in the press release:
As previously reported, the Company sued Midam, its Investor Relations consultant, for selling common stock of the Company in excess of the contractual Leak-Out Clause barring sales of more than 50,000 shares per day. The action was filed in state court in Miami, Florida.
The Company immediately sought a temporary injunction barring further sales in breach of its agreement with the Company, requiring an immediate buyback of all shares sold in breach of the agreement, and other temporary relief. On February 24, 2017, the court denied the request for temporary injunction, on the grounds that the Company’s contract with Midam required disputes to be handled in arbitration, and that the Company could seek the remedy of damages.
The court’s ruling was unrelated to the merits of the action — i.e., whether Midam breached its contract with the Company and, if so, whether the Company is entitled to a remedy for that breach. The court’s order was based solely on whether Progressive was entitled to a court-issued injunction at this early stage.
Progressive has agreed to the case being resolved in an arbitration proceeding. The court, on March 3, 2017, entered an agreed order staying the court case pending arbitration.
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Click here to read the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.